Opinions expressed by Entrepreneur contributors are their own. As I sit in my home office atop a mountain in Upstate New York, I realize there were no mistakes in growing my business — just a lot of missteps that turned out to be part of the path up the mountain of growth. I never imagined…
Disclosure: Our goal is to feature products and services that we think you’ll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from our commerce partners. Real estate investors have always been lauded as finding the niche that’s most impervious to recession and best…
A great business idea is worth nothing, until you can find paying customers. But how? Here’s a start: Think like the founders of Facet. It’s an online financial advisor platform that spent years (and multiple pivots) figuring out how to get members. Now it has 18,000 of them, and brings in $35 million in annual…
Opinions expressed by Entrepreneur contributors are their own. In a world where innovation often takes center stage, Codie Sanchez, the visionary founder of Contrarian Thinking, reminds us that sometimes, the path to success lies in thinking differently. In a recent interview on The Jeff Fenster Show, Codie shared her inspiring journey of launching a business…
Opinions expressed by Entrepreneur contributors are their own. Picture this: You’re in the middle of a new project at work and everything is just flowing. You’re at the top of your productivity game — coming up with novel ideas and feeling a rush of excitement as you conjure up sentence after sentence with nary a…
Solid foothold of personalized medicine, increasing prevalence of chronic diseases, favorable government initiatives, and rapid digital transformation are opening new avenues for biotech companies. Thus, it could be wise to invest in fundamentally sound biotech stocks BioMarin Pharmaceutical (BMRN), Shionogi (SGIOY), and Exelixis (EXEL)for potential gains. Read on…. Despite a challenging macro environment, the biotech…
This company is in the sweet spot when it comes to higher mortgage rates. Its required insurance product is in increasing demand as home prices outstrip the ability of most buyers to pay 20% down. Enact (ACT) should be on your radar as a housing market play that can win in a variety of scenarios.…